Company / Total Assets
INOVIO PHARMACEUTICALS, INC. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$74.3M
FY2025
5-year range
$74.3M / $495.9M
FY2021-FY2025
Trend
-34.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 5 consecutive years, from $540M in FY2020 to $74M in FY2025.
Based on SEC 10-K filings.
$74M in FY2025 with a 5-year CAGR of -32.7%.
Declined from $171M to $74M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -40.3%
- 5-Year CAGR
- -32.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- INOVIO PHARMACEUTICALS, INC.'s total assets has declined for 5 consecutive years.
- 5-year CAGR of -32.7%, indicating a declining trend.
- In FY2025, total assets decreased 34.4% year-over-year.
- Peak total assets was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $74.3M | -34.4% |
| FY2024 | $113.2M | -33.8% |
| FY2023 | $171.0M | -51.0% |
| FY2022 | $348.5M | -29.7% |
| FY2021 | $495.9M | -8.1% |
| FY2020 | $539.8M | +275.0% |
| FY2019 | $144.0M | +9.8% |
| FY2018 | $131.1M | -30.0% |
| FY2017 | $187.2M | +7.8% |
| FY2016 | $173.7M | -18.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026